Skip to search formSkip to main contentSkip to account menu

antiperinuclear factor

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
Objective: To study the value of antibodies to citrullinated proteins/peptides for predicting joint outcomes in patients with… 
Highly Cited
2003
Highly Cited
2003
Objective: To evaluate a contribution of selected laboratory parameters for a prediction of progressive and erosive development… 
Highly Cited
1999
Highly Cited
1999
OBJECTIVE To study the prognostic value of the antiperinuclear factor (APF), determined by an indirect immunofluorescence test… 
Highly Cited
1996
Highly Cited
1996
The goal of this prospective longitudinal study was to determine the serological profile of early rheumatoid arthritis (RA), and… 
Highly Cited
1995
Highly Cited
1995
The so-called antikeratin antibodies (AKA) and the antiperinuclear factor (APF) are the most specific serological markers of RA… 
Review
1994
Review
1994
Highly Cited
1993
Highly Cited
1993
OBJECTIVE Antikeratin antibody (AKA) and antiperinuclear factor (APF) are antibodies characteristic for rheumatoid arthritis (RA… 
Highly Cited
1992
Highly Cited
1992
The diagnosis of rheumatoid arthritis (RA) is first of all based on clinical manifestations. Serological support for such a… 
Highly Cited
1985
Highly Cited
1985
Sera from patients with rheumatoid arthritis (RA), patients with infectious mononucleosis (IM), and blood donors were tested by… 
Highly Cited
1981
Highly Cited
1981
Tests for antiperinuclear factor (APF) demonstrable by indirect immunofluorescence (IF) on smears of human buccal mucosal cells…